Keystone Symposia Scientific Advisory Board

The Scientific Advisory Board (SAB) is comprised of eminent biomedical scientists whose expertise derives from academia, industry, and the government. The SAB is tasked with guiding the development of the conference portfolio, prioritizing content and topics, and providing a substantive peer review process to ensure Keystone Symposia's reputation as the preeminent convener of scientific conferences in the biomedical and life sciences.

To learn more about the functions of the SAB, please click here.

Board of Directors are denoted with a # following their name.


E. Dale Abel, M.D., Ph.D.#
Director F.O.E. Diabetes Research Center
Professor of Medicine and Biochemistry
University of Iowa, Carver College of Medicine

George Addona, Ph.D.
Executive Director
Pharmacology
Merck Research Labs

Clement Adebamowo, B.M., Ch.B., Hons, Sc.D.
Professor Epidemiology and Public Health
Associate Director Population Science,
Greenebaum Comprehensive Cancer Center
Member, Institute of Human Virology
University of Maryland School of Medicine

Luciano Adorini, M.D.
Chief Scientific Officer
Preclinical Research
Intercept Pharmaceuticals, Inc.

James E. Audia, Ph.D.
Chief Scientific Officer
Constellation Pharmaceuticals

Eric H. Baehrecke, Ph.D.
Professor
Department of Molecular, Cell and Cancer Biology
University of Massachusetts Medical School

Jacques F. Banchereau, Ph.D.
Professor and Director of Immunological Sciences
The Jackson Laboratory for Genomic Medicine

Dominic P. Behan, Ph.D., D.Sc.
Co-Founder and Chair
Scientific Advisory Board
Arena Pharmaceuticals, Inc.

Yasmine Belkaid, Ph.D.
Director NIAID Microbiome Program
Chief Mucosal Immunology Section
Laboratory of Parasitic Disease
National Institute of Health, NIAID

Ralph A. Bradshaw, Ph.D.#
Professor Emeritus
Department of Physiology and Biophysics
University of California, Irvine

Cherié L. Butts, Ph.D.#
Associate Director
Portfolio Leadership
Biogen

Robert Califf, M.D., MACC#
Donald F. Martin, MD Professor of Cardiology
Duke University
School of Medicine

Roger D. Cone, Ph.D.
Director
Life Sciences Institute
University of Michigan

Rodrigo Corrêa-Oliveira, Ph.D.
Vice President
Research and Biological Collections
FIOCRUZ

Russell A. DeBose-Boyd, Ph.D.
Professor
Molecular Genetics
University of Texas Southwestern Medical Center

Edward A. Dennis, Ph.D.#
Professor
Chemistry, Biochemistry and Pharmacology
School of Medicine
University of California, San Diego

Vishva M. Dixit, M.D.#
Vice President, Early Discovery Research and Physiological Chemistry
Genentech, Inc.

Lisa Drew, Ph.D.
Director
Oncology Bioscience
AstraZeneca

Aris N. Economides, Ph.D.
Vice President
Research
Regeneron Pharmaceuticals, Inc.

Martin P. Edwards, Ph.D.
Vice President
Oncology Medicinal Chemistry
Cancer Research Chemistry
Pfizer La Jolla

Markus Enzelberger, Ph.D.
Senior Vice President
Discovery, Alliances and Technologies
MorphoSys AG

Peter M. Finan, Ph.D.#
Venture Partner
Epidarex Capital

Stacey Gabriel, Ph.D.
Senior Director
Genomics Platform
The Broad Institute

Adolfo García-Sastre, Ph.D.
Professor
Department of Microbiology
Mount Sinai School of Medicine

Tariq Ghayur, Ph.D.
Senior Research Fellow
Biologics
AbbVie Inc.

Geoffrey S. Ginsburg, M.D., Ph.D.
Director, Center for Applied Genomics and Precision Medicine
Center for Applied Genomics and Center for Personalized and Precision Medicine
Duke University

Margaret A. Goodell, Ph.D.#
Professor, Pediatrics
Director of Stem Cells & Regenerative Medicine Center
Baylor College of Medicine

Bryan Goodwin, PhD
Senior Director
Gastrointestinal, Metabolic, and Endocrine Therapeutic Area
Shire

Austin Gurney, Ph.D.
Senior Vice President, Molecular & Cellular Biology
OncoMed Pharmaceuticals, Inc.

Curtis C. Harris, M.D.#
Chief, Laboratory of Human Carcinogenesis
NCI / National Institutes of Health

Sharath S. Hegde, Ph.D.
Senior Vice President, Research
Pharmacology
Theravance Biopharma

De' Broski R. Herbert, Ph.D.
Associate Professor of Infectious Immunology
School of Veterinary Medicine
University of Pennyslvania

Linda Slanec Higgins, Ph.D.
Vice President , Biology
Gilead Sciences, Inc.

Sean Hill, Ph.D.
Professor
Blue Brain Project
École Polytechnique Fédérale de Lausanne (EPFL)

Steve Hitchcock, Ph.D.
Head of Research
Takeda Pharmaceuticals International Co.

Michael C. Holmes, Ph.D.
Vice President of Research
Sangamo Therapeutics, Inc.

Michael J. Holtzman, MD
Herman and Selma Seldin Professor of Medicine
Director, Pulmonary and Critical Care Medicine
Washington University in St. Louis

Reid M. Huber, Ph.D.
Executive Vice President, Chief Scientific Officer
Discovery Biology
Incyte Corporation

Tony Hunter, Ph.D.
Professor, Molecular Biology and Cellular Biology Laboratory
The Salk Institute

Thale C. Jarvis, Ph.D.#
Chief Scientific Officer
Keystone Symposia

Allan R. Jones, Ph.D.
Chief Executive Officer
Allen Institute for Brain Science

Takashi Kadowaki, M.D., Ph.D.
Professor and Chairman
Graduate School of Medicine, Diabetes and Metabolic Diseases
University of Tokyo

Christopher L. Karp, M.D.
Deputy Director, Vaccines & Host-Pathogen Biology
Global Health Discovery & Translational Sciences
Bill & Melinda Gates Foundation

Karla A. Kirkegaard, Ph.D.
Violetta Horton Professor
Genetics & Microbiology & Immunology
Stanford University School of Medicine

Christian Klein, Ph.D.
Distinguished Scientist
Roche Pharmaceutical Research & Development
Roche Innovation Center Zürich
Roche Glycart AG

Martin Kussmann, Ph.D.
Professor, Systems Biology in Nutrition and Health
Liggins Institute, University of Auckland
Chief Scientist, High Value Nutrition
A New Zealand National Science Challenge

Jeffrey L. Kutok, M.D., Ph.D.
Chief Scientific Officer
Infinity Pharmaceuticals, Inc.

Tony K.T. Lam, Ph.D.
Professor and J.K. McIvor Endowed Chair in Diabetes Research
Canada Research Chair in Obesity
Associate Director, Banting and Best Diabetes Centre
Advanced Diagnostics and Metabolism
Toronto General Research Institute

Philip J. Larsen, M.D., Ph.D.
Global Head Diabetes Discovery and Early Clinical Development
R&D, Germany
Sanofi

Jan E. Leach, Ph.D.
University Distinguished Professor
Bioagricultural Sciences
Colorado State University

Hyam I. Levitsky, M.D.
Executive Vice President
Research & Chief Scientific Officer
Juno Therapeutics

Dangsheng Li, Ph.D.
Deputy Editor-in-Chief
Cell Research
Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences

Juan Carlos Lopez, Ph.D.#
Founder
Haystack Science

Timothy B. Lowinger, Ph.D.
Chief Scientific Officer
Mersana Therapeutics

Paolo G. V. Martini, Ph.D.
Chief Scientific Officer
Elpidera, a Moderna Venture

Lamine Mbow, Ph.D.
Executive Director
Immunology & Respiratory Disease Research
Boehringer Ingelheim

M. Juliana McElrath, M.D., Ph.D.
Senior Vice President, Director and Member
Vaccine and Infectious Disease Division
Fred Hutchinson Cancer Research Center

Elizabeth M. McNally, M.D., Ph.D.
Director
Center for Genetic Medicine
Northwestern University Feinberg School of Medicine

Juanita L. Merchant, M.D., Ph.D.
H. Marvin Pollard Professor of Gastrointestinal Sciences
Departments of Internal Medicine and Molecular and Integrative Physiology
University of Michigan

Tara Mirzadegan, Ph.D.
Senior Director
CREATe
Janssen R&D: Pharmaceutical Companies of Johnson & Johnson

Craig Monell, Ph.D.
Vice President
Business Operations/R&D
BioLegend, Inc.

Walter H. Moos, Ph.D.#
President (ret.), SRI Biosciences
Professor (adj.), University of California, San Francisco

Dominik Mumberg, Ph.D.
Vice President
Oncology II
Bayer HealthCare

Leon O. Murphy, Ph.D.
Entrepreneur-in-Residence
Third Rock Ventures

Vic E. Myer, Ph.D.
Chief Technology Officer
Editas Medicine, Inc.

Gary J. Nabel, M.D., Ph.D.#
Chief Scientific Officer
Research and Development
Sanofi

Steven G. Nadler, Ph.D.
Executive Director
Translational Research Immuno-Sciences
Biology Drug Discovery
Bristol-Myers Squibb Company

Anne O'Garra, Ph.D., FRS, FMedSci#
Associate Research Director
The Francis Crick Institute
Mill Hill Laboratory

Gary Paul O'Neill, Ph.D.
Vice President, Biology and Drug Discovery
Department of Biology and Drug Discovery
Abide Therapeutics Inc.

Eric M. Parker, Ph.D.
Synergy Partners R&D Solutions

Paul W. H. I. Parren, Ph.D.
Leiden University Medical Center

Jane L. Peterson, Ph.D.#
President and Chief Executive Officer
Keystone Symposia

Roberto D. Polakiewicz, Ph.D.
Chief Scientific Officer
Cell Signaling Technology, Inc.

Mark Powers, Ph.D.
Senior Director, Research and Development
Cell Biology
Thermo Fisher Scientific

Bali Pulendran, Ph.D.
Professor
Emory Vaccine Center
Emory University

Laszlo Radvanyi, Ph.D.
Senior Vice President, Global Head of Immuno-Oncology R&D
Immuno-Oncology Translational Innovation Platform
EMD Serono / Merck KgaA, Darmstadt Germany

Ronald Raines, Ph.D.
Professor
Departments of Biochemistry and Chemistry
University of Wisconsin - Madison

Richard M. Ransohoff, M.D.
Vice President
Neuroimmunology and Acute Neurology
Biogen

Bing Ren, Ph.D.
Professor
Ludwig Institute for Cancer Research

Cristina M. Rondinone, Ph.D.
Vice President, Research and Development
Head, Cardiovascular and Metabolic Diseases
MedImmune, Inc.

Kei Sakamoto, Ph.D.
Head, Diabetes and Circadian Rhythms
Nestlé Institute of Health Sciences

Alejandro Sánchez Alvarado, Ph.D.
Investigator
Stowers Institute for Medical Research/HHMI

Ali Shilatifard, Ph.D.
Robert Francis Furchgott Professor
Chairman, Department of Biochemistry and Molecular Genetics
Northwestern University Feinberg School of Medicine

Frank J. Slack, Ph.D.
Director
Institute for RNA Medicine
Pathology
BIDMC Cancer Center/Harvard Medical School

Barry P. Sleckman, M.D., Ph.D.
Vice Chair for Research
Pathology and Laboratory Medicine
Weill Cornell Medical College

Hans Ulrich Stilz, Ph.D.
Vice President
R&D Academic Partnerships
Novo Nordisk A/S

Lynda M. Stuart, M.D., Ph.D.
Deputy Director
Global Health, Discovery & Translational Sciences
Bill & Melinda Gates Foundation

Eric E. Swayze, Ph.D.
Vice President
Medicinal Chemistry
Ionis Pharmaceuticals

Paul K.H. Tam, ChM
Provost and Deputy Vice-Chancellor
Li Shu-Pui Professor and Chair of Pediatric Surgery
The University of Hong Kong

Cormac Taylor, Ph.D.
Professor of Cellular Physiology
Medicine
University College Dublin

Fred Van Goor, Ph.D.
Principal Research Fellow
Research
Vertex Pharmaceuticals Incorporated

Joanne L. Viney, Ph.D.
JLV Biotech Consulting

Michael J.O. Wakelam, Ph.D.
Institute Director
The Babraham Institute

Bruce D. Walker, M.D.#
Director
Ragon Institute of MGH, MIT & Harvard

Yibin Wang, Ph.D.
Professor
Anesthesiology, Physiology and Medicine
University of California, Los Angeles
David Geffen School of Medicine

Andrew B. Ward, Ph.D.
Associate Professor
Integrative Structural and Computational Biology
The Scripps Research Institute

Stephanie Wengert Watts, Ph.D.
Professor, Assistant Dean
Pharmacology & Toxicology
Michigan State University

Keith M. Wilcoxen, Ph.D.
Senior Director
Scientific Research and Development
TESARO, Inc.

Joseph C. Wu, M.D., Ph.D.
Professor and Director of Stanford Cardiovascular Institute
Medicine and Radiology
Stanford University School of Medicine

Tadataka Yamada, M.D.#
Managing Partner
Mountain Field LLC

Xuebiao Yao, Ph.D.
Professor and Head
Cellular Dynamics
University of Science & Technology of China

Bei B. Zhang, Ph.D.#
Vice President, Metabolic Research
Worldwide Research and Development
Internal Medicine
Pfizer Inc.

Michael J. Zigmond, Ph.D.
Professor of Neurology, Psychiatry and Behavioral and Community Health Sciences
Neurology
University of Pittsburgh

plus representatives to be announced from:
Akebia Therapeutics
Amgen Inc.
Bioverativ Therapeutics
Celgene Corporation
Eli Lilly and Company
ImmunoGen, Inc.
Novartis Institutes for BioMedical Research